Insulin, combination of fast acting with intermediate-acting or long-acting

No definition available.

Endpoint definition

FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries KELA purch., KELA reimb.

Medicine purchases: ATC A10AD30
Medicine purchases: ATC: other data required >3 instances required

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector INSULIN_INTER_AND_LONG_WITH_FAST

Extra metadata

First used in FinnGen datafreeze DF2

Similar endpoints

List of similar endpoints to Insulin, combination of fast acting with intermediate-acting or long-acting based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

None

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals - - -
Unadjusted prevalence (%) - - -
Mean age at first event (years) - - -

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Correlations

Index endpoint: INSULIN_INTER_AND_LONG_WITH_FAST – Insulin, combination of fast acting with intermediate-acting or long-acting
GWS hits:

Survival analyses between endpoints

Plot

before Insulin, combination of fast acting with intermediate-acting or long-acting
after Insulin, combination of fast acting with intermediate-acting or long-acting

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Insulin, combination of fast acting with intermediate-acting or long-acting